There are 130 to 150 million people with chronic Hepatitis C all over the world from which almost 500 000 die each year because of cirrhosis or cancer. This disease does not spread through food, water, or casual contact.
Hepatitis C is a liver infection caused by a virus which spreads through the blood or body fluids of an infected person.
You can be contaminated:
There are different genotypes of Hepatitis C in the world. In Algeria the most common one is genotype 1. It is also the case in the United States, Canada or France for example.
There has been some new treatment for Hepatits C developed by multinationals however at a very high cost. Laboratoires BEKER® has decided therefore to engage itself in finding a solution accessible for the patient by developing the generic version of Sofosbuvir, Sofos® at a cost 70 times lower than the branded drug.
Sofos® is a drug used to treat infection with hepatitis C in adults (18+).
The treatment works by reducing the amount of the virus in your body and eliminating it from your blood after a while.
Sofos® is always taken with other drugs. Alone, it is not efficient. It is frequently prescribed with: ribavirin, peginterferon alfa plus or ribavirin, or in combination with other interferon-free. Please refer to your doctor for the details of your treatment.